- Home
- FOXX vs COSM Comparison
FOXX vs COSM Comparison
Compare FOXX & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FOXX | COSM |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9M | 18.8M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | FOXX | COSM |
|---|---|---|
| Price | $4.31 | $0.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 74.7K | ★ 441.7K |
| Earning Date | 02-13-2026 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $63,030,415.00 | $59,792,819.00 |
| Revenue This Year | N/A | $28.14 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 139.29 | 6.69 |
| 52 Week Low | $1.71 | $0.28 |
| 52 Week High | $11.00 | $1.32 |
Technical Indicators
Market Signals| Indicator | FOXX | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 51.47 | 44.94 |
| Support Level | $4.00 | $0.50 |
| Resistance Level | $4.87 | $0.56 |
| Average True Range (ATR) | 0.54 | 0.04 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 55.10 | 46.78 |
Price Performance
Historical ComparisonAbout FOXX Foxx Development Holdings Inc.
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.